Metastatic cancer is associated with an invariably fatal outcome accounting for 8.8 million deaths worldwide in 2015, a global burden which is expected to increase beyond 13 million by 2030 (World Health Organization, 2018; American Cancer Society, 2018). It is our mission to support the timely development of innovative targeted therapies for cancers and other diseases.